Stroop-CN: A rapid diagnostic tool for minimal hepatic encephalopathy

FHS
July 19, 2024
11:43 pm

This study is led by Dr. Xiaolong Qi (Center of Portal Hypertension, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology) and Dr. Junliang Fu (Senior Department of Infectious Diseases, the Fifth Medical Center of Chinese PLA General Hospital, National Clinical Research Center for Infectious Diseases).

Galecto terminates development for its lead candidate – Pharmaceutical Technology

Galecto CEO stated, “Given the impact of the results from the GALACTIC-1 trial on our future plans, we are currently evaluating resource allocation with the

August 16, 2023

Seelos’ stock plunges by over 75% after ketamine drug for suicide prevention fails a PhII trial

Seelos Therapeutics’ intranasal racemic ketamine candidate has missed the primary endpoint in a Phase II trial of major depressive disorder patients with acute suicidal ideation,

September 21, 2023

M&A: Tendo Acquires MDsave for $150M

What You Should Know: – Tendo, a digital health company committed to creating seamless healthcare experiences for patients, clinicians, and caregivers announced it has acquired

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.